Skip to content
10-Q

Quarterly Report

Seaport Therapeutics, Inc. SPTX

0001193125-26-260678

← back to feed
Filed
Jun 8, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Jun 5, 2026 53.53M sh
Shares Diluted Q1 2026 · Mar 31, 2026 2.46M sh
Shares Diluted Q1 2026 · Mar 31, 2025 2.32M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $54K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$20.17M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$20.21M
Short Term Investments Q1 2026 · Mar 31, 2026 $129.7M
Short Term Investments Q1 2026 · Dec 31, 2025 $169.94M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $52.91M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $46.04M
Stockholders Equity Q1 2026 · Mar 31, 2026 −$115.62M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$92.55M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$36.16M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$24.85M
Current Liabilities Q1 2026 · Mar 31, 2026 $14.22M
Current Liabilities Q1 2026 · Dec 31, 2025 $12.78M
Total Liabilities Q1 2026 · Mar 31, 2026 $17.97M
Total Liabilities Q1 2026 · Dec 31, 2025 $16.23M
Current Assets Q1 2026 · Mar 31, 2026 $188.34M
Current Assets Q1 2026 · Dec 31, 2025 $223.23M
Total Assets Q1 2026 · Mar 31, 2026 $227.67M
Total Assets Q1 2026 · Dec 31, 2025 $249.01M
Eps Diluted Q1 2026 · Mar 31, 2026 −$10.34
Eps Diluted Q1 2026 · Mar 31, 2025 −$5.65
Eps Basic Q1 2026 · Mar 31, 2026 −$10.34
Eps Basic Q1 2026 · Mar 31, 2025 −$5.65
Sga Expense Q1 2026 · Mar 31, 2026 $6.11M
Sga Expense Q1 2026 · Mar 31, 2025 $5.65M
Rd Expense Q1 2026 · Mar 31, 2026 $21.43M
Rd Expense Q1 2026 · Mar 31, 2025 $10.53M
Net Income Q1 2026 · Mar 31, 2026 −$25.41M
Net Income Q1 2026 · Mar 31, 2025 −$13.13M
Operating Income Q1 2026 · Mar 31, 2026 −$27.54M
Operating Income Q1 2026 · Mar 31, 2025 −$16.19M